Moderna and OpenAI announced an ongoing partnership Wednesday to embed AI across Moderna’s business, giving its teams — ...

The English part of a global dispute billion dollar legal case involving big pharma giants Modern, Pfizer and BioNTech over ...

Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines ...

The World Health Organization has recommended updating COVID-19 vaccine formulations to reflect the dominant SARS-CoV-2 ...

Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...

CAMBRIDGE, MA / ACCESSWIRE / April 25, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present data ...

Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the ...

COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.

Moderna announced a partnership with OpenAI, the company behind ChatGPT, to further incorporate AI across its mRNA drug ...

Within the 3 months after vaccination, 8.6% of patients had anterior uveitis, and 1.6% nonanterior uveitis. The total rates ...

CAMBRIDGE, MA / ACCESSWIRE / April 22, 2024 /(NASDAQ:MRNA) today announced a contract with the Ministry of Health in Brazil ...

CDC states that already an estimated 97% of Americans have some level of immunity, from either vaccination or infection or ...